Quest Diagnostics Added To Goldman Sachs Conviction Buy List

By: via Benzinga
Quest Diagnostics (NYSE: DGX) was added to the Conviction Buy list Wednesday morning at Goldman Sachs. The price target was raised ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.